This information is for research and educational purposes only. No medical recommendations. Products are not approved for human use. For health questions, consult a doctor.

Lexicon

IGF-1 LR3

An IGF-1 variant with very weak binding to carrier proteins: markedly more potent and longer acting than natural IGF-1, even though it leaves the blood faster.

3 min read 8 sources

Vial with white powder, a blue cap and a black TPD label for IGF-1 LR3 on a white podium, next to it a structural model of the IGF-1 core made of blue glass spheres, without the LR3 extension
Preclinical · not approved

Summary

At a glance

Sources checked on 26 Oct 2026

More potent than IGF-1
~6 -fold

around a sixth of the amount gave a similar effect in rats1

Weight gain, nitrogen, feed efficiency
bis +26 %

with IGF-1 at the highest amount over 14 days, LR3 reached similar values with less (rats)1

Longer low blood sugar
bis 8 -fold

summed over 4 hours, IGF-1 variants versus IGF-1 (pigs, monkeys)3

Own GH
-23 %

mean after 4 days of infusion, growth fell (pigs)5

Human trials in the registry
0 trials

no trial with IGF-1 LR3, as of 26 Oct 20267

  • IGF-1 LR3 is a variant of insulin-like growth factor 1 with an extended start and arginine instead of glutamate at position 3. As a result it barely binds the IGF-binding proteins.1
  • In rats around a sixth of the amount gave similar weight gain, nitrogen retention and feed efficiency as natural IGF-1.1
  • LR3 is cleared from the blood faster than IGF-1 but acts more strongly. In pigs and monkeys IGF-1 variants lowered blood sugar for much longer.23
  • Not all findings are positive: in food-restricted rats LR3 did not protect the muscles; in pigs it suppressed the body's own growth hormone and slowed growth.45
  • The registry lists no human trial and there is no approval. Everything here is preclinical research, not a recommendation.7
Profile

Updated May 2026

Class
IGF-1 analogue

Long R3

Use
Subcutaneous

daily

Half-life
shorter in the blood than natural IGF-1

faster clearance, yet the effect lasts longer

WADA
Banned

growth factors

Sizes
0.1 to 1 mg

2 sizes in the shop

Contents 16 sections
  1. At a glance
  2. What is IGF-1 LR3?
  3. How it works
  4. What you need
  5. Reconstitution
  6. Dosing
  7. Injection
  8. What the research shows
  9. Research status
  10. Side effects
  11. Practice
  12. Storage
  13. Related compounds
  14. FAQ
  15. Glossary
  16. Sources

What is IGF-1 LR3?

IGF-1 LR3 (Long R3 IGF-1) is a modified form of insulin-like growth factor 1. Two changes to the sequence mean it barely binds the natural carrier proteins (IGFBPs). As a result more of it is free and active. It does leave the blood faster than natural IGF-1, but the effect lasts longer, for example the lowering of blood sugar (Tomas et al., 1996 and 1997).

In research IGF-1 LR3 is common mainly as a reagent for cell culture. In humans there is no approval and only a thin data record.

Comparison

Where on the GH-IGF-1 axis each one acts

From bottom to top: IGF-1 itself, growth hormone and the two triggers at the pituitary, as described in the TPD lexicon. Tap a card to open its entry.

Simplified: IGF-1 LR3 acts directly on the IGF-1 receptor. In pigs it suppressed the body's own growth hormone in doing so. 5

How it works

IGF-1 mediates many of the anabolic effects otherwise credited to growth hormone: it promotes cell growth, protein building and the uptake of nutrients into the cell. Through the IGF-1 receptor it also acts on muscle and connective tissue.

The LR3 variant is interesting because the weak carrier-protein binding makes it act longer than natural IGF-1, even though it is cleared from the blood faster. But that is exactly what makes it more potent and therefore more sensitive to dose.

Where it acts

Where LR3 acted in animal studies

Tap a point or a card. Colour = receptor, grey = observed. All from animal studies.

  1. Muscle and body

    More weight and nitrogen, but no muscle protection with scarce food (rats)4

    IGF1R
  2. Blood sugar

    Blood sugar fell more strongly and for longer than with IGF-1 (pigs, monkeys)3

    Observed in trials
  3. Pituitary

    Own GH fell by 23 percent on average (pigs)5

    Observed in trials

Known targets3

Compound IGF-1-Variante, nicht in ChEMBL: one described target, Activates the receptor like IGF-1, barely held back by binding proteins.

IGF-1 receptor
Gene
IGF1R
UniProt
P08069
ChEMBL
CHEMBL1957
Action
Activates the receptor like IGF-1, barely held back by binding proteins
Structural models of the IGF-1 core made of blue glass spheres, without the LR3 extension, dock onto hollows of translucent cells, small glowing spheres stream into the cells
IGF-1 acts via the IGF-1 receptor, shown is the IGF-1 core without the LR3 extension. Symbolic image.

What you need

Supplies

4 things, numbered as in the picture

Tick off what you already have. Vial and BAC water are our real shop photos at the same size.

IGF-1 LR3 vial and bacteriostatic water at the same size with the black TPD label, next to two U-100 insulin syringes, two alcohol swabs and a sharps container with a blue lid
  1. IGF-1 LR3 vial

    The IGF-1 LR3 vial (lyophilized powder, usually 1mg).

    In the shop
  2. Bacteriostatic water

    Bacteriostatic water for mixing.

    In the shop
  3. U-100 insulin syringes

    U-100 insulin syringes.

  4. Alcohol swabs

    Alcohol swabs and a clean workspace.

As an Amazon associate we earn from qualifying purchases. Links open Amazon - no extra cost for you.

Reconstitution

Use the peptide calculator: pick the vial size (usually 1mg) and water amount, it shows concentration and units per dose on the U-100 syringe.

A 1mg vial with 1ml bacteriostatic water gives 1000mcg per ml. A 50mcg dose is then 5 units on the insulin syringe. Just add the water and let it dissolve.

Step by step

Dissolving the powder

Four steps, the same for every vial size.

  1. 1Wipe the cap

    Clean the rubber stopper with an alcohol swab.

  2. 2Add BAC water

    Just add it, it does not matter if it hits the powder directly.

  3. 3Swirl or shake

    Until everything has dissolved, both are fine.

  4. 4Draw up

    With the U-100 insulin syringe.

Less water higher concentration fewer units on the syringe Example: 1 mg + 1 ml = 1 mg/ml

Dosing

Dosing

Dosing, titration and syringe

Loading the dosing information …

  • Getting started and stepping up, drawn as a staircase
  • Units on the U-100 syringe for every step
  • How long one vial lasts

Injection

The injection is subcutaneous, into the fat layer under the skin. Common spots are the abdomen (keep about two finger-widths clear of the navel), the front and the inner side of the thigh, or the back of the upper arm. Use the short insulin needle for this.

The short version:

Injection

Where and at what angle

Pick a spot or switch the angle. Subcutaneous means: into the fat layer, not the muscle.

Rotate the spot each time, never the same one twice in a row.

90°More fat under the skin

Rule of thumb: where there is more fat under the skin, insert straight at 90 degrees. In lean people with little fat, 45 degrees, so the needle stays in the fat layer. Simplified diagram.

  1. Clean the spot with an alcohol swab and let it dry

  2. Pinch up a small fold of skin

  3. Insert the needle: at 90 degrees where there is more fat under the skin, at 45 degrees in lean people with little fat

  4. Inject slowly, wait a moment, then withdraw

  5. Put the needle straight into the sharps container

Rotate the site each time so the tissue does not get irritated. Never the same spot twice in a row.

Because IGF-1 acts insulin-like, watch for low-blood-sugar signs and do not overdose while fasted.

What the research shows

An older, cleanly published study (Tomas, 1993) compared natural IGF-1 with the LR3 variant in rats. Result: both promoted weight gain and nitrogen retention, but LR3-IGF-1 was markedly more potent because of the weak carrier-protein binding.

That supports the mechanism but it is animal research. Modern human studies specifically on LR3 and muscle building in healthy people are missing. No approval exists either.

Study results

What the trials measured

Interactive: switch tabs, tap points, show or hide arms. Arms are named relative to each other, no dosing advice.

How strongly IGF-1 variants lowered blood sugar3

Natural IGF-1 = 1, upper end of the range from the study

Lowest blood sugar3 2 to 3 times stronger
Natural IGF-1 1-fold
IGF-1 variants with weak IGFBP binding 3-fold
Low blood sugar over 4 hours3 4 to 8 times more
Natural IGF-1 1-fold
IGF-1 variants with weak IGFBP binding 8-fold

Several variants including LR3 were tested in pigs and marmosets. At equally strong lowering the low blood sugar of the variants lasted about twice as long overall.

What LR3 did to the body's own growth hormone5

Change after 4 days of infusion in finishing pigs

Mean GH in the blood5
IGF-1 LR3 -23%
Area under the GH peaks5
IGF-1 LR3 -60%

Along with the body's own GH, IGF-1, IGFBP-3 and insulin in the blood fell and the animals grew less. Extra GH did not reverse this effect.

Stainless steel lab cart with petri dishes of pink cell culture, a frosted glass muscle sculpture on the top tray
The comparison with natural IGF-1 comes from experiments in rats, human studies on LR3 are missing. Symbolic image.

Research status

Where the research stands

Where the compound stands on the way from lab research to approval. As of 26 Oct 2026.

  1. Preclinical Animal studies in rats, pigs and monkeys
  2. Phase 1 no registered trial
  3. Phase 2 no registered trial
  4. Phase 3 no registered trial
  5. Approval not yet
Not approved and no registered human trial. Only IGF-1 with the natural sequence (mecasermin) is approved, not the LR3 variant.7

So far there is no registered trial in humans.

Side effects

  • Insulin-like action with a risk of low blood sugar (shaking, sweating, ravenous hunger), especially fasted.
  • Local reactions at the injection site.
  • Theoretical concern: IGF-1 promotes cell growth generally, which can be critical with pre-existing growths. Long-term human safety data are missing.

Practice

  1. Start low (around 20mcg) and watch closely.

  2. Keep fast carbs handy in case of low-blood-sugar signs.

  3. Limit cycles because of the fading receptor response.

  4. Banned in official competition.

Banana, a glass of orange juice, a folded white towel and two blue dumbbells on a light wooden bench in a gym

Storage

Before mixing the powder is robust, normal room temperature (around 20 to 25 degrees) is fine, ideally kept in the dark. After mixing, keep in the fridge (2 to 8 degrees), do not freeze. It stays good there for at least 4 to 6 months with barely any loss of potency, in practice considerably longer. Swirl or shake to mix, both are fine.

Shelf life

How long it keeps

Undissolved (powder) Room temperature, around 20 to 25 degrees, dark

Robust, no fridge needed. Keeps for several months without trouble.

Dissolved (mixed) Fridge, 2 to 8 degrees, do not freeze

At least 4 to 6 months with barely any loss of potency. The bacteriostatic water brings a preservative.

  • Keep it dark
  • Dissolved: 2 to 8 degrees
  • Note the mixing date on the vial
Nine vials with white powder and blue caps in the door shelf of a bright fridge
Powder dark at room temperature, once dissolved into the fridge (2 to 8 degrees), stable there for at least 4 to 6 months. Symbolic image.

Related

Related compounds

A different path: all in the TPD lexicon.

FAQ

Common questions about IGF-1 LR3

Short answers, each backed by the sources below.

Is IGF-1 LR3 approved or studied in humans?

No. ClinicalTrials.gov lists no trial with IGF-1 LR3 (as of 26 October 2026). Only IGF-1 with the natural sequence (mecasermin) is approved as a medicine, not the LR3 variant. LR3 is mainly common as an additive for cell cultures.78

What is different from natural IGF-1?

LR3 has an extra piece of chain at the start and arginine instead of glutamate at position 3. As a result it barely binds the IGF-binding proteins that capture IGF-1 in the blood. In rats around a sixth of the amount gave a similar effect as natural IGF-1.1

Does LR3 stay in the blood longer?

According to the studies, no: because LR3 is barely bound to binding proteins it is cleared from the blood faster than IGF-1. It still acts more strongly, even with one dose a day. In pigs and monkeys IGF-1 variants lowered blood sugar much longer than IGF-1.23

Does LR3 build muscle?

In growing rats weight gain and nitrogen retention rose while body proportions stayed the same. In food-restricted rats LR3 kept weight somewhat higher but did not protect muscle protein. In adult animals it even increased protein breakdown. There are no human studies.14

How is LR3 linked to low blood sugar?

IGF-1 acts similarly to insulin. In pigs and marmosets IGF-1 variants with weak binding to binding proteins, including LR3, lowered blood sugar 2 to 3 times more strongly than IGF-1. Summed over 4 hours the low blood sugar was 4 to 8 times greater.3

What happens to the body's own growth hormone?

In finishing pigs on LR3 the body's own growth hormone fell by 23 percent on average and the area under the GH peaks by 60 percent. IGF-1, IGFBP-3 and insulin in the blood fell too and the animals grew less.5

What is known about quality?

A doping lab in Cologne found LR3 with an attached His tag, a purification add-on from lab production, in a black market vial. How this form acts in humans has not been studied.6

Glossary

Terms explained briefly

Dotted words in the text open these explanations directly.

Cell culture
Cells grown in nutrient solution in the lab. LR3 is used there as a growth additive.
Growth hormone (GH)
A pituitary hormone that among other things stimulates the production of IGF-1.
IGF-1
Insulin-like growth factor 1. Made mainly in the liver when growth hormone acts, it carries many of its effects.
IGF-1 receptor
A receptor on many cells through which IGF-1 triggers growth and protein building.
IGF-binding proteins
Proteins in the blood that hold on to IGF-1, slowing and distributing its action. LR3 barely binds them.
Low blood sugar
Blood sugar that is too low. Signs are shaking, sweating and ravenous hunger.
Lyophilisate
Freeze-dried powder. Without water a peptide keeps much longer.
Nitrogen retention
How much nitrogen the body keeps. Protein contains nitrogen, so more retention means more protein building.
Preclinical
Studied in cells or animals, not yet in humans.
Subcutaneous
Into the fat layer just under the skin.

Evidence

Sources

Show all 8 sourcesHide sources 6 Studies1 Trial registry1 Database checked 26 Oct 2026

Studies

  1. IGF-1 and LR3 in healthy female rats

    Tomas et al., Journal of Endocrinology, 1993

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  2. LR3 as infusion and as injection (rats)

    Tomas et al., Journal of Endocrinology, 1996

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  3. IGF-1 variants and blood sugar (pigs, marmosets)

    Tomas et al., Journal of Endocrinology, 1997

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  4. LR3 during food restriction (rats)

    Tomas, Growth Hormone & IGF Research, 2001

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  5. LR3 lowers own GH and growth (pigs)

    Dunaiski et al., Journal of Endocrinology, 1997

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  6. LR3 with a His tag in a black market product

    Kohler et al., Growth Hormone & IGF Research, 2010

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed

Trial registry

  1. Search on ClinicalTrials.gov (no trial with IGF-1 LR3)

    ClinicalTrials.gov, U.S. National Library of Medicine

    Checked 26 Oct 2026 via ClinicalTrials.gov API v2

Database

  1. IGF-1 with the natural sequence (mecasermin) in ChEMBL

    ChEMBL, EMBL-EBI (CHEMBL1201716, Ziel CHEMBL1957)

    Checked 26 Oct 2026 via ChEMBL

In the shop

IGF-1 LR3 in the catalog

Sizes, prices and shipping times are on the product page.

To the product